Table: Cosmos Pharmaceutical -2016/17 parent results
Jul 10 (Reuters)-
Cosmos Pharmaceutical Corp.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
May 31, 2017 May 31, 2016 May 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 502.73 447.27
(+12.4 pct) (+9.5 pct)
Operating 22.20 18.63
(+19.2 pct) (+9.3 pct)
Recurring 24.56 20.67
(+18.8 pct) (+6.6 pct)
Net 18.19 12.42
(+46.5 pct) (+2.9 pct)
EPS 918.95 yen 627.27 yen
Ann Div 80.00 yen 65.00 yen 90.00 yen
-Q2 Div 35.00 yen 30.00 yen 45.00 yen
-Q4 Div 45.00 yen 35.00 yen 45.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T
((Tokyo Headline News Desk +813 6441 1812))